Tapas K. Das Gupta, M.D., Ph.D., D.Sc., Founder and Chairman Emeritus. Since 1968, Dr. Das Gupta has served as a professor and in 1990, became Department Head in the Department of Surgical Oncology at the University of Illinois at Chicago. Dr. Das Gupta received his MD degree from the University of Calcutta (India), and his Ph.D. and D. Sc. from London University (England). He is board certified in Surgery.
Dr. Das Gupta has authored more than 440 publications, served on FDA advisory panels, and has taken part in numerous clinical trials.
David R. Volk, President and Chief Executive Officer. Previously, Mr. Volk was a founder and principal of White Oak Advisors, a consulting firm providing financial and strategic advisory services to start-up and emerging growth life sciences companies. Prior to White Oak Advisors, Mr. Volk was managing director and Head of Life Sciences Investment Banking for RBC Capital Markets. In that capacity, Mr. Volk managed an investment banking group which raised private and public growth capital for companies ranging from early-stage through initial public offering and thereafter.
Mr. Volk received his B.A. in economics from the University of California at Berkeley, and his MBA from the Kellogg School at Northwestern University.
Craig W. Beattie, Ph. D., Chief Science Officer. From 2000 through 2005, Dr. Beattie served as a professor in the Department of Animal Biotechnology at the University of Nevada at Reno. He served as Chair of the Department from 2000 until 2003. From 2000 until 2005, Dr. Beattie served as a director of the Nevada Genome Center. Prior to the University of Nevada, he served as a professor in the Department of Veterinary PathoBiology at the University of Minnesota.
Dr. Beattie received his B.S. and M.S in Biology from Fairleigh Dickinson University, and his Ph.D. in Biological Sciences from the University of Delaware.
Steven E. Fleck, Chief Financial Officer. Prior to joining CDG in 2005, Mr. Fleck served as Director of Accounting for Northfield Laboratories Inc., where he served in various roles in the company's accounting, finance and IT departments dating back to 1988.
Mr. Fleck received his B.A. in economics from the University of Illinois and his MBA from Northern Illinois University.
Tohru Yamada, Ph.D., Director of Drug Development. From 2004 through 2007, Dr. Yamada served as a Research Assistant Professor at the Department of Surgical Oncology, University of Illinois College of Medicine. Prior to that appointment, Dr. Yamada was a Post-Doctoral Fellow in the school's Department of Microbiology & Immunology.
Dr. Yamada received his B.S., M.S. and Ph.D. in Medical Biotechnology from Tokyo Institute of Technology, Japan.